SCHEMBL12499770

SCHEMBL12499770

C[C@@H]1CNC[C@H](C)N1Cc1ccc(Br)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
SLC6A4 P31645 2/20 0.37
HTR2C P28335 4/20 0.35
HTR2A P28223 3/20 0.35
HTR2B P41595 3/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
SIGMAR1 Q99720 1/20 0.34
LMNA P02545 2/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 2/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
RECQL P46063 1/20 0.33
RAB9A P51151 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20432698 0.81 HTR2C (0.50) ALDH1A1HTR2CHTR2AHTR2BSIGMAR1
SCHEMBL17086789 0.81 HTR2C (0.50) ALDH1A1HTR2CHTR2AHTR2BSIGMAR1
SCHEMBL20432699 0.81 HTR2C (0.50) ALDH1A1HTR2CHTR2AHTR2BSIGMAR1
SCHEMBL1310132 0.81 HTR2C (0.50) ALDH1A1HTR2CHTR2AHTR2BSIGMAR1
SCHEMBL1310133 0.81 HTR2C (0.50) ALDH1A1HTR2CHTR2AHTR2BSIGMAR1
Hydrochloric Acid SCHEMBL3155670 0.80 CHRM2 (0.53) ALDH1A1HTR2CHTR2AHTR2BSIGMAR1
SCHEMBL29147689 0.80 ALDH1A1 (0.42) ALDH1A1KDM4ESIGMAR1HPGDPOLB
Hydrochloric Acid SCHEMBL3155675 0.80 CHRM2 (0.53) ALDH1A1HTR2CHTR2AHTR2BSIGMAR1
SCHEMBL1427504 0.80 ALDH1A1 (0.42) ALDH1A1KDM4ESIGMAR1HPGDPOLB
SCHEMBL12499953 0.79 KDM4E (0.40) ALDH1A1KDM4ECYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3826724-B1 NOVEL PIPERAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE HOFFMANN LA ROCHE (CH) 2022-10-05 EP disclosed
EP-3826724-A1 NOVEL PIPERAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2021-06-02 EP disclosed
CN-112584903-A Novel piperazine compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2021-03-30 CN disclosed
WO-2020020800-A1 NOVEL PIPERAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-01-30 WO disclosed
WO-2020020800-A1 NOVEL PIPERAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-01-30 WO disclosed
WO-2012048411-A1 PLK-4 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME UNIVERSITY HEALTH NETWORK (CA) 2012-04-19 WO disclosed